RARA CRAFT DATABASE for FDA Medical Devices
510(k)K172456

FDA DEVICE FACTS

Bone Screws 6.5mm

Lima Corporate S.P.A.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEJanuary 4, 2018PRODUCT CODELPH

Indications for use

The SMR Shoulder System is intended for partial or total, primary or revision shoulder joint replacement. The SMR Anatomic Shoulder System is indicated for partial or total, primary or revision shoulder joint replacement in patients suffering from disability due to:  non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis;  inflammatory degenerative joint disease such as rheumatoid arthritis;  treatment of acute fractures of the humeral head that cannot be treated with other fracture fixation methods;  revision of a failed primary implant;  cuff tear arthropathy (CTA Heads only);  glenoid arthrosis without excessive glenoid bone loss: A1, A2 and B1 according to Walch classification (SMR Hybrid Glenoid only). The SMR Reverse Shoulder System is indicated for primary, fracture or revision total shoulder replacement in a grossly rotator cuff deficient joint with severe arthropathy (disabled shoulder). The patient’s joint must be anatomically and structurally suited to receive the selected implants and a functional deltoid muscle is necessary to use the device. The Hybrid Reverse Baseplate must not be used in cases of excessive glenoid bone loss and/or when bone graft is needed. The Modular SMR Shoulder System allows the assembly of components in various humeral and glenoid constructs. The constructs are intended for cemented and uncemented use as specified in the following table. In the Anatomic shoulder the humeral construct consists of the humeral stem, the humeral body, the adaptor taper and the humeral head. In the Reverse shoulder the humeral construct consists of the humeral stem, the reverse humeral body and the reverse liner. On the humeral side the fixation of the humeral stem determines if the construct is cemented or uncemented. The Anatomic glenoid construct consists of an all polyethylene glenoid, a polyethylene glenoid with metal peg or a metal back assembled with a liner; the Reverse glenoid consists of a metal back/connector/glenosphere construct or of a peg/baseplate/glenosphere construct. On the glenoid side, the fixation of the all polyethylene glenoid, the polyethylene glenoid with metal peg or the metal back determines if the construct is cemented or uncemented. System Components Material Use A R Cem Not Cem  SMR Stems (Cemented, Cemented Revision) Ti6Al4V X  SMR Stems (Cementless Finned, Cementless Revision) Ti6Al4V X  SMR Humeral Bodies (Trauma, Finned) Ti6Al4V X X  SMR Reverse Humeral Body Ti6Al4V X X  Humeral Extension Ti6Al4V X X  SMR Humeral Heads (Standard, CTA) CoCrMo X X  SMR Adaptor Tapers (Neutral, Eccentric) Ti6Al4V X X  SMR CTA Head Adaptor for Reverse Humeral Body Ti6Al4V X X  SMR Glenospheres CoCrMo X  SMR Connectors Ti6Al4V X  Reverse Liners UHMWPE X X  SMR Cemented Glenoids UHMWPE X  SMR 3 Pegs Cemented Glenoids UHMWPE X  * SMR Hybrid Glenoid UHMWPE+Ti6Al4V+Ta X X  SMR Hybrid Reverse Baseplate + Screw Ti6Al4V X  SMR Metal Back Glenoids Ti6Al4V+PoroTi X* X*  SMR TT Metal Back Baseplate Ti6Al4V X* X*  SMR TT Metal Back Peg Ti6Al4V X X  SMR Metal Back Liner UHMWPE X* X*  *  SMR Bone screws Ti6Al4V X Material Standards Ti6Al4V (ISO 5832-3 - ASTM F1472) - CoCrMo (ISO 5832-12 - ASTM F1537) – UHMWPE (ISO 5834-2 - ASTM F648) - PoroTi Titanium Coating (ASTM F1580) - Ta (ISO13782 - ASTM F560) A= Anatomic / R=Reverse *NOTE :  In the US, the SMR Metal Backed Glenoid/Liner construct, used as part of the SMR Anatomic Shoulder Replacement, is intended for use with bone cement and should be used without bone screws.  The SMR Metal Backed Glenoid/Connector/Glenosphere construct, used as part of the SMR Reverse Shoulder replacement, is intended for uncemented use with the addition of screws for fixation.  In the US the SMR TT Metal Back Baseplate used as part of the SMR Anatomic Shoulder Replacement, is intended for use with bone cement and should be used without bone screws; while when used as part of the SMR Reverse Shoulder replacement, is intended for uncemented use with the addition of screws for fixation.  If a SMR Hybrid Glenoid is in place and revision to a reverse prosthesis is required, the patient can be revised by removing the polyethylene baseplate, leaving the metal peg in place and by connecting it to the SMR Hybrid Reverse Baseplate. The SMR Hybrid Reverse Baseplate is intended for uncemented use with the addition of screws for fixation. The Dia. 50, 52 and 54 mm Humeral Heads with + 3mm increased height cannot be coupled to the Long Adaptor Tapers (both concentric and eccentric). The Dia. 52 and 54 mm Humeral Heads with + 2mm increased height cannot be coupled to the Long Adaptor Tapers (both concentric and eccentric). The Delta TT Acetabular System is indicated for use in total hip arthroplasty for reduction or relief of pain and/or improved hip function in skeletally mature patients with the following conditions:  Non-inflammatory degenerative joint disease such as osteoarthritis, avascular necrosis and hip dysplasia;  Rheumatoid arthritis;  Post-traumatic arthritis,  Correction of functional deformity;  Fractures, dislocation of the hip and unsuccessful cup arthroplasty. Revisions in cases of good remaining bone stock.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 28, 2026